DE602004018637D1 - A2a-adenosinrezeptorantagonisten - Google Patents
A2a-adenosinrezeptorantagonistenInfo
- Publication number
- DE602004018637D1 DE602004018637D1 DE602004018637T DE602004018637T DE602004018637D1 DE 602004018637 D1 DE602004018637 D1 DE 602004018637D1 DE 602004018637 T DE602004018637 T DE 602004018637T DE 602004018637 T DE602004018637 T DE 602004018637T DE 602004018637 D1 DE602004018637 D1 DE 602004018637D1
- Authority
- DE
- Germany
- Prior art keywords
- adenosine receptor
- receptor antagonistic
- formula
- antagonists
- discovery
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 101150051188 Adora2a gene Proteins 0.000 title abstract 2
- 230000003042 antagnostic effect Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 208000018737 Parkinson disease Diseases 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US46148403P | 2003-04-09 | 2003-04-09 | |
PCT/US2004/011009 WO2004092173A2 (en) | 2003-04-09 | 2004-04-09 | A2a adenosine receptor antagonists |
Publications (1)
Publication Number | Publication Date |
---|---|
DE602004018637D1 true DE602004018637D1 (de) | 2009-02-05 |
Family
ID=33299825
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE602004018637T Expired - Lifetime DE602004018637D1 (de) | 2003-04-09 | 2004-04-09 | A2a-adenosinrezeptorantagonisten |
Country Status (6)
Country | Link |
---|---|
US (1) | US7834014B2 (de) |
EP (1) | EP1633756B1 (de) |
AT (1) | ATE418555T1 (de) |
DE (1) | DE602004018637D1 (de) |
HK (1) | HK1083838A1 (de) |
WO (1) | WO2004092173A2 (de) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060106040A1 (en) | 2002-12-19 | 2006-05-18 | Michael Grzelak | Adenosine A2a receptor antagonists for the treatment of extra-pyramidal syndrome and other movement disorders |
EP2258372B8 (de) | 2005-06-07 | 2012-12-19 | Kyowa Hakko Kirin Co., Ltd. | A2A Antagonisten zur Behandlung von motorischen Störungen |
US7728031B2 (en) | 2006-02-24 | 2010-06-01 | Abbott Laboratories | Octahydro-pyrrolo[3,4-b]pyrrole derivatives |
EP1939197A1 (de) | 2006-12-22 | 2008-07-02 | Schwarz Pharma Ag | 8-Ethinylxanthinderivate als selektive Antagonisten des A2A-Rezeptors |
RU2486187C2 (ru) | 2007-09-11 | 2013-06-27 | Эбботт Лэборетриз | N-ОКСИДЫ ОКТАГИДРО-ПИРРОЛО[3,4-b]ПИРРОЛА |
ES2658892T3 (es) * | 2008-07-23 | 2018-03-12 | Kyowa Hakko Kirin Co., Ltd. | Agente terapéutico para la migraña |
WO2011106688A1 (en) | 2010-02-26 | 2011-09-01 | Catabasis Pharmaceuticals, Inc. | Bis-fatty acid conjugates and their uses |
WO2011109681A1 (en) | 2010-03-05 | 2011-09-09 | Catabasis Pharmaceuticals, Inc. | Fatty acid cox inhibitor derivatives and their uses |
WO2011116312A1 (en) | 2010-03-19 | 2011-09-22 | Catabasis Pharmaceuticals, Inc. | Fatty acid macrolide derivatives and their uses |
JP6377068B2 (ja) | 2012-11-16 | 2018-08-22 | ユニバーシティ・ヘルス・ネットワーク | ピラゾロピリミジン化合物 |
WO2014101120A1 (en) * | 2012-12-28 | 2014-07-03 | Merck Sharp & Dohme Corp. | Heterobicyclo-substituted-7-methoxy-[1,2,4]triazolo[1,5-c]quinazolin-5-amine compounds with a2a antagonist properties |
WO2018045071A1 (en) | 2016-08-31 | 2018-03-08 | Agios Pharmaceuticals, Inc. | Inhibitors of cellular metabolic processes |
AU2018237598B2 (en) | 2017-03-24 | 2023-12-14 | Piksci Inc. | Fused triazolo-pyrimidine compounds having useful pharmaceutical application |
PL3611174T3 (pl) * | 2017-04-07 | 2022-08-08 | Medshine Discovery Inc. | Pochodne [1,2,4]triazolo[1,5-c]pirymidyny jako inhibitor receptora a2a |
CN109535161B (zh) * | 2017-09-22 | 2021-09-03 | 江苏恒瑞医药股份有限公司 | ***并嘧啶类衍生物、其制备方法及其在医药上的应用 |
JP7474709B2 (ja) | 2018-02-27 | 2024-04-25 | インサイト・コーポレイション | A2a/a2b阻害剤としてのイミダゾピリミジン及びトリアゾロピリミジン |
GB201804922D0 (en) * | 2018-03-27 | 2018-05-09 | Ucl Business Plc | Traatment |
US11168089B2 (en) | 2018-05-18 | 2021-11-09 | Incyte Corporation | Fused pyrimidine derivatives as A2A / A2B inhibitors |
CN111164084B (zh) * | 2018-06-26 | 2023-05-23 | 浙江春禾医药科技有限公司 | 可用作a2a受体拮抗剂的***并三嗪衍生物 |
GEP20237560B (en) | 2018-07-05 | 2023-10-25 | Incyte Corp | Fused pyrazine derivatives as a2a / a2b inhibitors |
TWI829857B (zh) | 2019-01-29 | 2024-01-21 | 美商英塞特公司 | 作為a2a / a2b抑制劑之吡唑并吡啶及***并吡啶 |
US20230048888A1 (en) * | 2019-12-26 | 2023-02-16 | Zhejiang Vimgreen Pharmaceuticals, Ltd. | Use of triazolotriazine derivative in treatment of diseases |
WO2023191400A1 (ko) * | 2022-04-01 | 2023-10-05 | 에이치케이이노엔 주식회사 | 에틸 피페리딘 트리아졸로 트리아진 유도체, 이의 제조방법 및 이를 포함하는 암의 예방 또는 치료용 약학적 조성물 |
Family Cites Families (50)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL7406641A (de) | 1973-05-22 | 1974-11-26 | ||
JPS56131586A (en) | 1980-03-18 | 1981-10-15 | Ss Pharmaceut Co Ltd | Triazolopyrimidine derivative and its preparation |
JPS56131587A (en) | 1980-03-18 | 1981-10-15 | Ss Pharmaceut Co Ltd | 7-substituted triazolopyrimidine derivative and its preparation |
JPS5962595A (ja) | 1982-09-30 | 1984-04-10 | Ss Pharmaceut Co Ltd | 3,5,7―トリ置換―トリアゾロピリミジン誘導体 |
DE3304330A1 (de) | 1983-02-09 | 1984-08-09 | Basf Ag, 6700 Ludwigshafen | Neue 2h-v-triazolyl(4,5-d)-pyrimidine und deren verwendung |
JPS60140335A (ja) | 1983-12-28 | 1985-07-25 | Konishiroku Photo Ind Co Ltd | 熱現像カラ−感光材料 |
US5204353A (en) | 1987-04-07 | 1993-04-20 | Ciba-Geigy Corporation | 3-benzyl-3H-1,2,3-triazolo[4,5-d]pyrimidines, compositions thereof, and method of treating epilepsy therewith |
WO1990008148A1 (en) | 1989-01-23 | 1990-07-26 | Pfizer Inc. | Bis-aza-bicyclic anxiolytic agents |
ZA902280B (en) | 1989-03-29 | 1990-12-28 | Merrell Dow Pharma | Selective adenosine receptor agents |
ES2079391T3 (es) | 1989-04-17 | 1996-01-16 | Bayer Ag | Procedimiento para la obtencion de 2,7-diazabiciclo(3.3.0)octanos. |
GB2240102B (en) | 1990-01-22 | 1993-10-20 | Biochemie Gmbh | Improvements in or relating to beta lactam production |
US5356894A (en) * | 1990-05-29 | 1994-10-18 | Rodney Peter W | Morpholinyl substituted [1,2,4]-triazolo[1,5-a]triazine as antagonist |
JPH0436284A (ja) | 1990-05-29 | 1992-02-06 | Sumitomo Chem Co Ltd | ジフェニルフロピリミジン誘導体、その製造法およびそれを有効成分とする除草剤 |
GB2244487B (en) | 1990-05-29 | 1994-02-02 | Ici Plc | Azole derivatives |
CA2100863A1 (en) | 1991-01-23 | 1992-07-24 | David A. Bullough | Adenosine kinase inhibitors |
GB9111130D0 (en) | 1991-05-23 | 1991-07-17 | Ici Plc | Azole derivatives |
ATE359842T1 (de) | 1991-07-02 | 2007-05-15 | Nektar Therapeutics | Abgabevorrichtung für nebelförmige medikamente |
PL175347B1 (pl) | 1992-04-03 | 1998-12-31 | Upjohn Co | Trójpierścieniowe heterocykliczne aminy aktywne farmaceutycznie |
TW444018B (en) | 1992-12-17 | 2001-07-01 | Pfizer | Pyrazolopyrimidines |
NZ258690A (en) | 1992-12-17 | 1997-01-29 | Pfizer | Pyrrolopyrimidines and pharmaceutical compositions containing such compounds; intermediate pyrrole compounds |
KR0170567B1 (ko) | 1992-12-17 | 1999-02-18 | 알렌 제이. 스피겔 | 부신피질자극호르몬-유리 인자 길항물질 활성을 갖는 피라졸 및 피라졸로피리미딘 |
US6005109A (en) | 1997-10-30 | 1999-12-21 | Pflizer Inc. | Pyrazoles and pyrazolopyrimidines having CRF antagonistic activity |
IL108523A0 (en) | 1993-02-03 | 1994-05-30 | Gensia Inc | Pharmaceutical compositions containing adenosine kinase inhibitors for preventing or treating conditions involving inflammatory responses and pain |
WO1995003806A1 (fr) | 1993-07-27 | 1995-02-09 | Kyowa Hakko Kogyo Co., Ltd. | Remede contre la maladie de parkinson |
CA2148502A1 (en) | 1993-09-06 | 1995-03-16 | Fumio Suzuki | Antidepressants |
EP0723533A1 (de) | 1993-10-12 | 1996-07-31 | The Du Pont Merck Pharmaceutical Company | N-alkyl-n-arylpyrimidinamine und ihre derivate |
SK283206B6 (sk) | 1995-07-11 | 2003-03-04 | Astra Pharmaceuticals Ltd. | Inhibítory agregácie krvných doštičiek, spôsob ich prípravy, farmaceutická kompozícia s ich obsahom a ich použitie |
US5789416B1 (en) | 1996-08-27 | 1999-10-05 | Cv Therapeutics Inc | N6 mono heterocyclic substituted adenosine derivatives |
AU743910B2 (en) * | 1997-03-24 | 2002-02-07 | Kyowa Hakko Kirin Co., Ltd. | {1,2,4}triazolo{1,5-c}pyrimidine derivatives |
JP2002510322A (ja) | 1997-07-03 | 2002-04-02 | デュポン ファーマシューティカルズ カンパニー | 副腎皮質刺激ホルモン放出ホルモン拮抗剤としてのアリールおよびアリールアミノ置換複素環 |
HRP980375A2 (en) | 1997-07-03 | 1999-04-30 | Argyrios Georgios Arvanitis | Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders |
US5939432A (en) | 1997-10-29 | 1999-08-17 | Medco Research, Inc. | Thiophenes useful for modulating the adenosine receptor |
AU1251499A (en) | 1997-11-26 | 1999-06-15 | Cerebrus Limited | (-)-mefloquine to block purinergic receptors and to treat movement or neurodegenerative disorders |
US6579868B1 (en) | 1998-01-05 | 2003-06-17 | Eisai Co., Ltd. | Purine derivatives and adenosine A2 receptor antagonists serving as preventives/remedies for diabetes |
US6187777B1 (en) | 1998-02-06 | 2001-02-13 | Amgen Inc. | Compounds and methods which modulate feeding behavior and related diseases |
WO1999043678A1 (fr) * | 1998-02-24 | 1999-09-02 | Kyowa Hakko Kogyo Co., Ltd. | Medicaments et prophylaxie contre la maladie de parkinson |
JPH11279193A (ja) | 1998-03-24 | 1999-10-12 | Akira Matsuda | アデノシン誘導体 |
AP1411A (en) | 1998-06-02 | 2005-05-10 | Osi Pharm Inc | Pyrrolo[2,3d] pyrimidine compositions and their use. |
GB9819382D0 (en) | 1998-09-04 | 1998-10-28 | Cerebrus Ltd | Chemical compounds I |
GB9819384D0 (en) | 1998-09-04 | 1998-10-28 | Cerebrus Ltd | Chemical compounds II |
CA2344828A1 (en) | 1998-09-22 | 2000-03-30 | Tomoyuki Kanda | ¬1,2,4|triazolo¬1,5-c|pyrimidine derivatives |
TW564247B (en) | 1999-04-08 | 2003-12-01 | Akzo Nobel Nv | Bicyclic heteraromatic compound |
GB9915437D0 (en) | 1999-07-01 | 1999-09-01 | Cerebrus Ltd | Chemical compounds III |
US6841549B1 (en) | 1999-07-02 | 2005-01-11 | Eisai Co., Ltd. | Condensed imidazole compounds and a therapeutic agent for diabetes mellitus |
PL203805B1 (pl) | 2000-02-25 | 2009-11-30 | Hoffmann La Roche | Zastosowanie cyklicznych związków heteroaromatycznych, lek i cykliczne związki heteroaromatyczne |
JPWO2003020723A1 (ja) | 2001-08-30 | 2004-12-16 | 協和醗酵工業株式会社 | [1,2,4]トリアゾロ[1,5−a]ピリミジン誘導体 |
JP4429724B2 (ja) | 2001-11-30 | 2010-03-10 | シェーリング コーポレイション | [1,2,4]−トリアゾール二環式アデノシンA2aレセプタアンタゴニスト |
JPWO2003068776A1 (ja) * | 2002-02-15 | 2005-06-02 | 協和醗酵工業株式会社 | [1,2,4]トリアゾロ[1,5−c]ピリミジン誘導体 |
EP1544200A1 (de) * | 2002-09-24 | 2005-06-22 | Kyowa Hakko Kogyo Co., Ltd. | 1,2,4-TRIAZOLO 1,5-c PYRIMIDINDERIVAT |
WO2004092170A2 (en) * | 2003-04-09 | 2004-10-28 | Biogen Idec Ma Inc. | Triazolotriazines and pyrazolotriazines useful as a2a adenosine receptor antagon ists |
-
2004
- 2004-04-09 WO PCT/US2004/011009 patent/WO2004092173A2/en active Application Filing
- 2004-04-09 DE DE602004018637T patent/DE602004018637D1/de not_active Expired - Lifetime
- 2004-04-09 EP EP04759359A patent/EP1633756B1/de not_active Expired - Lifetime
- 2004-04-09 US US10/552,304 patent/US7834014B2/en not_active Expired - Fee Related
- 2004-04-09 AT AT04759359T patent/ATE418555T1/de not_active IP Right Cessation
-
2006
- 2006-03-30 HK HK06103960.4A patent/HK1083838A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
US20070173505A1 (en) | 2007-07-26 |
WO2004092173A2 (en) | 2004-10-28 |
ATE418555T1 (de) | 2009-01-15 |
US7834014B2 (en) | 2010-11-16 |
WO2004092173A3 (en) | 2004-12-09 |
HK1083838A1 (en) | 2006-07-14 |
EP1633756A2 (de) | 2006-03-15 |
EP1633756B1 (de) | 2008-12-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1083838A1 (en) | A2a adenosine receptor antagonists | |
RS20050616A (en) | Pyrazoles and methods of making and using the same | |
MXPA05002442A (es) | Imidazolopiridinas y metodos para la elaboracion y uso de las mismas. | |
RS95904A (en) | Tri -substituted heteroaryls and methods for making and using the same | |
EA200501333A1 (ru) | 5,7-ДИАМИНОПИРАЗОЛО[4,3-d]ПИРИМИДИНЫ, ПОЛЕЗНЫЕ ПРИ ЛЕЧЕНИИ ГИПЕРТЕНЗИИ | |
TW200621753A (en) | Pyrimidinylimidazoles and methods of making and using the same | |
ATE461196T1 (de) | Benzodiazepin-cgrp-rezeptor-antagonisten | |
WO2003042214A3 (en) | A2b adenosine receptor antagonists | |
TW200621752A (en) | Pyrimidinylpyrazoles and methods of making and using the same | |
CY1105879T1 (el) | Αζαδικυκλο παραγωγα ως ανταγωνιστες μουσκαρινικου υποδοχεα | |
DE60041710D1 (de) | Polycycloalkylpurine als adenosinrezeptorantagonisten | |
CY1109764T1 (el) | Υποκατεστημενα βενζαζολια και χρηση αυτων ως αναστολεις κινασης raf | |
WO2004091514A3 (en) | Cgrp receptor antagonists | |
BRPI0514661A (pt) | antagonistas de vasopressina v1a | |
BRPI0516242A (pt) | compostos tieno-pirimidina tendo atividade fungicida | |
RS20050200A (en) | Pyrazolopyridines and methods of making and using the same | |
MXPA03009185A (es) | Antagonistas de receptor a2a de adenosina combinados con compuestos de actividad neurotrofica en el tratamiento de la enfermedad de parkinson. | |
PL1620425T3 (pl) | Podstawione 3-cyjanotiofenoacetamidy jako antagoniści receptora glukagonu | |
WO2004092171A3 (en) | Triazolo[1,5-a]pyrimidines and pyrazolo[1,5-a]pyrimidines useful as a2a adenosin e receptor antagonists | |
DE60322748D1 (de) | Xanthinderivate als a2b-adenosinrezeptorantagonisten | |
WO2004092170A3 (en) | Triazolotriazines and pyrazolotriazines useful as a2a adenosine receptor antagon ists | |
ECSP044971A (es) | Isoxazolopiridinonas y su uso en el tratamiento de enfermedad de parkinson | |
WO2004092172A3 (en) | Triazolo[1,5-c]pyrimidines and pyrazolo[1,5-c]pyrimidines useful as a2a adenosin e receptor antagonists | |
DE502004007387D1 (de) | Triazolverbindungen und ihre therapeutische verwendung | |
UA80871C2 (en) | 5,7-diaminopyrazolo[4,3-d]pyrimidines useful in the treatment of hypertension |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |